Literature DB >> 21821561

Proportion of antidepressants prescribed without a psychiatric diagnosis is growing.

Ramin Mojtabai1, Mark Olfson.   

Abstract

Over the past two decades, the use of antidepressant medications has grown to the point that they are now the third most commonly prescribed class of medications in the United States. Much of this growth has been driven by a substantial increase in antidepressant prescriptions by nonpsychiatrist providers without an accompanying psychiatric diagnosis. Our analysis found that between 1996 and 2007, the proportion of visits at which antidepressants were prescribed but no psychiatric diagnoses were noted increased from 59.5 percent to 72.7 percent. These results do not clearly indicate a rise in inappropriate antidepressant use, but they highlight the need to gain a deeper understanding of the factors driving this national trend and to develop effective policy responses. To the extent that antidepressants are being prescribed for uses not supported by clinical evidence, there may be a need to improve providers' prescribing practices, revamp drug formularies, or vigorously pursue implementation of broad reforms of the health care system that will increase communication between primary care providers and mental health specialists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821561     DOI: 10.1377/hlthaff.2010.1024

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  69 in total

1.  Psychotropic medication claims among religious clergy.

Authors:  Steven M Frenk; Sarah A Mustillo; Steven L Foy; Whitney D Arroyave; Elizabeth G Hooten; Kari H Lauderback; Keith G Meador
Journal:  Psychiatr Q       Date:  2013-03

2.  A Canadian Primary Care Sentinel Surveillance Network Study Evaluating Antidepressant Prescribing in Canada From 2006 to 2012.

Authors:  Rachael Morkem; David Barber; Tyler Williamson; Scott B Patten
Journal:  Can J Psychiatry       Date:  2015-12       Impact factor: 4.356

3.  Antidepressant Prescribing in Primary Care to Older Adults Without Major Depression.

Authors:  Donovan T Maust; Jo Anne Sirey; Helen C Kales
Journal:  Psychiatr Serv       Date:  2017-01-03       Impact factor: 3.084

4.  Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study.

Authors:  Raymond Noordam; Nikkie Aarts; Katia M Verhamme; Miriam C M Sturkenboom; Bruno H Stricker; Loes E Visser
Journal:  Eur J Clin Pharmacol       Date:  2015-01-06       Impact factor: 2.953

5.  Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries.

Authors:  Anthony F Jorm; Scott B Patten; Traolach S Brugha; Ramin Mojtabai
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

6.  The Fracture of Relational Space in Depression: Predicaments in Primary Care Help Seeking.

Authors:  Elizabeth Bromley; David Kennedy; Jeanne Miranda; Cathy Donald Sherbourne; Kenneth B Wells
Journal:  Curr Anthropol       Date:  2016-08-15

7.  The Impact Of Medicare's Mental Health Cost-Sharing Parity On Use Of Mental Health Care Services.

Authors:  Benjamin Lê Cook; Michael Flores; Samuel H Zuvekas; Joseph P Newhouse; John Hsu; Rajan Sonik; Esther Lee; Vicki Fung
Journal:  Health Aff (Millwood)       Date:  2020-05       Impact factor: 6.301

8.  National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care.

Authors:  Donovan T Maust; Frederic C Blow; Ilse R Wiechers; Helen C Kales; Steven C Marcus
Journal:  J Clin Psychiatry       Date:  2017-04       Impact factor: 4.384

9.  Antidepressant use and glycemic control.

Authors:  Ramin Mojtabai
Journal:  Psychopharmacology (Berl)       Date:  2013-01-20       Impact factor: 4.530

10.  Are antidepressants effective in the acute and long-term treatment of depression? Sic et Non.

Authors:  Ronald Pies
Journal:  Innov Clin Neurosci       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.